These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38214355)
1. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy. Chen X; Yu S; Wang P; Zhao X; Sang G Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928 [TBL] [Abstract][Full Text] [Related]
4. Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine. Abdelkader H; Longman MR; Alany RG; Pierscionek B Int J Nanomedicine; 2016; 11():2815-27. PubMed ID: 27366062 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731 [TBL] [Abstract][Full Text] [Related]
7. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809 [TBL] [Abstract][Full Text] [Related]
8. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
9. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells. Almutairi FM; Abd-Rabou AA; Mohamed MS Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864 [TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Shi L; Tang C; Yin C Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells. Nokhodi F; Nekoei M; Goodarzi MT J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166 [TBL] [Abstract][Full Text] [Related]
12. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles. Umerska A; Corrigan OI; Tajber L Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753 [TBL] [Abstract][Full Text] [Related]
14. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170 [TBL] [Abstract][Full Text] [Related]
17. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release. Lin CW; Lu KY; Wang SY; Sung HW; Mi FL Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764 [TBL] [Abstract][Full Text] [Related]
18. Aptamer-modified chitosan-capped mesoporous silica nanoparticles for co-delivery of cytarabine and daunorubicin in leukemia. Heydari SR; Ghahremani MH; Atyabi F; Bafkary R; Jaafari MR; Dinarvand R Int J Pharm; 2023 Nov; 646():123495. PubMed ID: 37806507 [TBL] [Abstract][Full Text] [Related]
19. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]